Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway
Abstract
A connection between gut microbiota and Parkinson's disease (PD) indicates that dysbiosis of the gut microbiota might represent a risk factor for PD. Microbiota-targeted interventions, including probiotic Clostridium butyricum (Cb), have been recently shown to have favorable effects in PD by regulating microbiota-gut-brain axis. However, the potential beneficial roles and its mechanisms of Cb on PD were still unknown. Male C57BL/6 mice were subjected to a PD model-induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and were treated intragastrically with Cb for 4 weeks. The motor functions were assessed by a series of behavioral tests including pole test, beam walking teat, forced swimming test and open field test. The dopaminergic neuron loss, synaptic plasticity and microglia activation, as well as the levels of colonic glucagon-like peptide-1 (GLP-1), colonic G protein-coupled receptors GPR41/43 and cerebral GLP-1 receptors were assessed. Gut microbial composition was assessed by 16S rRNA sequencing analysis. Our results showed that oral administration of Cb could improve motor deficits, dopaminergic neuron loss, synaptic dysfunction and microglia activation in the MPTP-induced mice. Meanwhile, Cb treatment could reverse the dysbiosis of gut microbiota and the decreased levels of colonic GLP-1, colonic GPR41/43 and cerebral GLP-1 receptor in the MPTP-induced mice. These findings indicated that the neuroprotective mechanism of Cb on PD might be related to the improvement of abnormal gut microbiota-gut-brain axis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Administration of probiotic Clostridium butyricum triggers activation of colonic GPR41/43, resulting in inhibition of microglial activation and mitigation of PD-related pathologies in MPTP-treated mice.
“Notably, the administration of probiotic Clostridium butyricum triggers the activation of colonic GPR41/43, resulting in the inhibition of microglial activation and mitigation of PD-related pathologies in MPTP-treated mice.316”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [316]
Probiotics and prebiotics are capable of stimulating GLP-1 secretion and upregulating the expression of GLP-1R in the brain.
“probiotics and prebiotics are capable of stimulating GLP-1 secretion and upregulating the expression of GLP-1R in the brain.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [316]
Probiotic C. butyricum restores colonic GLP-1 levels and upregulates GLP-1R expression in the brains of MPTP-induced mice, accompanied by reduced microglial activation and PD pathologies.
“probiotic C. butyricum restores colonic GLP-1 levels and upregulates GLP-1R expression in the brains of MPTP-induced mice, accompanied by reduced microglial activation and PD pathologies.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [316]
MPTP intervention drastically changed the intestinal microbiota of PD mice, increasing Bacteroides, Escherichia-Shigella, and Dubosiella, and decreasing Akkermansia.
“According to our research, MPTP intervention drastically changed the intestinal microbiota of PD mice (Figure 5), increasing Bacteroides, Escherichia-Shigella, and Dubosiella, and decreasing Akkermansia (Figure 5), which is consistent with the findings of previous studies [47,66,67].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [67]
The MPTP mouse model was created using a previously reported technique.
“To create the MPTP mouse model, we applied a technique that was previously reported [25,26].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [26]
Neuroprotective effects of Clostridium butyricum in mice with induced Parkinson's disease seem to be due to amelioration of the abnormal gut-brain axis.
“Sun and colleagues [440] suggested that neuroprotective effects of Clostridium butyricum in mice with induced Parkinson's disease seem to be due to amelioration of the abnormal gut-brain axis.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [440]
Oral administration of Clostridium butyricum improved gut dysbiosis, motor deficits, microglia activation, synaptic dysfunction, and loss of dopaminergic neurons.
“The authors demonstrated that oral administration of the above-mentioned strain improved gut dysbiosis, motor deficits, microglia activation, synaptic dysfunction, and loss of dopaminergic neurons.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [440]
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404 · see citing works
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204 · see citing works
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651 · see citing works
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,108 · see citing works
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · see citing works
Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · see citing works
Glucose Sensing in L Cells: A Primary Cell Study
Reimann, F., Habib, A. M., Tolhurst, G., Parker, H. E., Rogers, G. J., & Gribble, F. M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.002 · Cited by 733 · see citing works
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642 · see citing works
Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587 · see citing works
Nøhr, M. K., Pedersen, M. H., Gille, A., Egerod, K. L., Engelstoft, M. S., Husted, A. S., Sichlau, R. M., Grunddal, K. V., Poulsen, S. S., Han, S., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1142 · Cited by 575 · see citing works
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554 · see citing works
Sun, J., Xu, J., Ling, Y., Wang, F., Gong, T., Yang, C., Ye, S., Ye, K., Wei, D., Song, Z., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0525-3 · Cited by 532 · see citing works
Self-citationOttman, N., Reunanen, J., Meijerink, M., Pietilä, T. E., Kainulainen, V., Klievink, J., Huuskonen, L., Aalvink, S., Skurnik, M., Boeren, S. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173004 · Cited by 522 · see citing works
Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., de Vos, W. D., & Satokari, R. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.04050-14 · Cited by 510 · see citing works
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · see citing works
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478 · see citing works
Karaki, S.-I., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J., & Kuwahara, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0140-x · Cited by 465 · see citing works
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445 · see citing works
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Qian, Y., Yang, X., Xu, S., Wu, C., Song, Y., Qin, N., Chen, S.-D., & Xiao, Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.016 · Cited by 409 · see citing works
Gut microbiota signatures of longevity
Kong, F., Hua, Y., Zeng, B., Ning, R., Li, Y., & Zhao, J. (2016) · Current Biology · doi:10.1016/j.cub.2016.08.015 · Cited by 371 · see citing works
Bifidobacteria modulate cognitive processes in an anxious mouse strain
Savignac, H. M., Tramullas, M., Kiely, B., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.044 · Cited by 365 · see citing works
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361 · see citing works
Brighton, C. A., Rievaj, J., Kuhre, R. E., Glasssmith, L. L., Schoonjans, K., Holst, J. J., Gribble, F. M., & Reimann, F. M. (2015) · Endocrinology · doi:10.1210/en.2015-1321 · Cited by 355 · see citing works
Bertilsson, G., Patrone, C., Zachrisson, O., Andersson, A., Dannaeus, K., Heidrich, J., Kortesmaa, J., Mercer, A., Nielsen, E., Rönnholm, H., et al. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21483 · Cited by 345 · see citing works
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works
Sun, J., Xu, J., Yang, B., Chen, K., Kong, Y., Fang, N., Gong, T., Wang, F., Ling, Z., & Liu, J. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900636 · Cited by 302 · see citing works
Self-citationChanges of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298 · see citing works
Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Hölscher, C. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0221 · Cited by 294 · see citing works
Harkavyi, A., Abuirmeileh, A. N., Lever, R., Kingsbury, A. E., Biggs, C. S., & Whitton, P. S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-19 · Cited by 290 · see citing works
Liu, W., Jalewa, J., Sharma, M., Li, G., Li, L., & Hölscher, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.054 · Cited by 246 · see citing works
Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study
De Pablo-Fernandez, E., Goldacre, R., Pakpoor, J., Noyce, A. J., & Warner, T. T. (2018) · Neurology · doi:10.1212/wnl.0000000000005771 · Cited by 242 · see citing works
G-Protein-Coupled Receptors in Intestinal Chemosensation
Reimann, F. M., Tolhurst, G., & Gribble, F. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.019 · Cited by 235 · see citing works
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M., & Koga, Y. (2017) · Scientific Reports · doi:10.1038/srep43522 · Cited by 229 · see citing works
Liu, J., Sun, J., Wang, F., Yu, X., Ling, Z., Li, H., Zhang, H., Jin, J., Chen, W., Pang, M., et al. (2015) · BioMed Research International · doi:10.1155/2015/412946 · Cited by 225 · see citing works
Self-citationLactobacillus fermentumME-3 – an antimicrobial and antioxidative probiotic
Mikelsaar, M., & Zilmer, M. (2009) · Microbial Ecology in Health and Disease · doi:10.1080/08910600902815561 · Cited by 225 · see citing works
Inflammation is genetically implicated in Parkinson’s disease
Dzamko, N., Geczy, C. L., & Halliday, G. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.028 · Cited by 222 · see citing works
Liu, J., Wang, F., Liu, S., Du, J., Hu, X., Xiong, J., Fang, R., Chen, W., & Sun, J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.3235 · Cited by 218 · see citing works
Self-citationTachon, S., Zhou, J., Keenan, M. J., Martin, R. J., & Marco, M. L. (2012) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2012.01475.x · Cited by 207 · see citing works
Li, H., Sun, J., Du, J., Wang, F., Fang, R., Yu, C., Xiong, J., Chen, W., Lu, Z., & Liu, J. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13260 · Cited by 185 · see citing works
Self-citationLeal, M. C., Casabona, J. C., Puntel, M., & Pitossi, F. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00053 · Cited by 175 · see citing works
Lai, F., Jiang, R., Xie, W., Liu, X., Tang, Y., Xiao, H., Gao, J., Jia, Y., & Bai, Q. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2620-x · Cited by 169 · see citing works
Sun, J., Wang, F., Hu, X., Yang, C., Xu, H., Yao, Y., & Liu, J. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02462 · Cited by 158 · see citing works
Self-citationInflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Mamik, M. K., & Power, C. (2017) · Brain : a journal of neurology · doi:10.1093/brain/awx133 · Cited by 151 · see citing works
Sun, J., Wang, F., Ling, Z., Yu, X., Chen, W., Li, H., Jin, J., Pang, M., Zhang, H., Yu, J., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.042 · Cited by 147 · see citing works
Self-citationBouchard, T. P., Malykhin, N. V., Martin, W. R. W., Hanstock, C. C., Emery, D. J., Fisher, N., & Camicioli, R. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.002 · Cited by 146 · see citing works
Sun, J., Liu, S., Ling, Z., Wang, F., Ling, Y., Gong, T., Fang, N., Ye, S., Si, J., & Liu, J. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b07313 · Cited by 145 · see citing works
Self-citationKim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136 · see citing works
Badawi, G. A., Fattah, M. A. A. E., Zaki, H. F., & Sayed, M. I. E. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0331-6 · Cited by 123 · see citing works
Wearable Ultrasound Improves Motor Function in an MPTP Mouse Model of Parkinson's Disease
Zhou, H., Niu, L., Xia, X., Lin, Z., Liu, X., Su, M., Guo, R., Meng, L., & Zheng, H. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2899631 · Cited by 113 · see citing works
Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
Yoon, G., Kim, Y., & Song, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104615 · Cited by 109 · see citing works
Liu, J., Fu, Y., Zhang, H., Wang, J., Zhu, J. F., Wang, Y., Guo, Y., Wang, G., Xu, T., Chu, M., et al. (2017) · Food & Function · doi:10.1039/c7fo00355b · Cited by 107 · see citing works
Self-citationKoutzoumis, D. N., Vergara, M., Pino, J. A., Buddendorff, J., Khoshbouei, H., Mandel, R. J., & Torres, G. E. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113159 · Cited by 103 · see citing works
Ducastel, S., Touche, V., Trabelsi, M.-S., Boulinguiez, A., Butruille, L., Nawrot, M., Peschard, S., Chávez-Talavera, O., Dorchies, E., Vallez, E., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56743-x · Cited by 84 · see citing works
Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77 · see citing works
Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72 · see citing works
Chen, S., Yu, S., Li, Y., Lecca, D., Glotfelty, E. J., Kim, H. K., Choi, H., Hoffer, B. J., Greig, N. H., Kim, D. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28449-z · Cited by 68 · see citing works
Fukuda, S., Nakagawa, S., Tatsumi, R., Morofuji, Y., Takeshita, T., Hayashi, K., Tanaka, K., Matsuo, T., & Niwa, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0696-1 · Cited by 53 · see citing works
Chen, F., Wang, W., Ding, H., Yang, Q., Dong, Q., & Cui, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0661-0 · Cited by 52 · see citing works
Bruns, R. F., Mitchell, S. N., Wafford, K. A., Harper, A. J., Shanks, E., Carter, G., O’Neill, M. J., Murray, T. K., Eastwood, B. J., Schaus, J. M., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.032 · Cited by 49 · see citing works
Exendin-4 improved rat cortical neuron survival under oxygen/glucose deprivation through PKA pathway
Wang, M., Huang, Y., Zhang, G.-P., Mao, L., Xia, Y., Mei, Y.-W., & Hu, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.025 · Cited by 48 · see citing works
Calvo-Rodríguez, M., Sanz‐Blasco, S., Caballero, E., Villalobos, C., & Núñez, L. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.13004 · Cited by 42 · see citing works
Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
Yamane, S., & Inagaki, N. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12762 · Cited by 42 · see citing works
Luo, D., Zhao, J., Cheng, Y., Lee, S. M., & Rong, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0486-6 · Cited by 40 · see citing works
Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
Gómez‐Soler, M., Cordobilla, B., Morató, X., Fernández‐Dueñas, V., Domingo, J. C., & Ciruela, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00604 · Cited by 39 · see citing works
A dynamic mouse peptidome landscape reveals probiotic modulation of the gut-brain axis
Zhang, P., Wu, X., Liang, S., Shao, X., Wang, Q., Chen, R., Zhu, W., Shao, C., Jin, F., & Jia, C. (2020) · Science Signaling · doi:10.1126/scisignal.abb0443 · Cited by 32 · see citing works
Naghibi, M. M., Day, R., Stone, S., & Harper, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091441 · Cited by 28 · see citing works
Emir, G. K., Ünal, Y., Yılmaz, N., Tosun, K., & Kutlu, G. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03975-4 · Cited by 20 · see citing works
[Features of gut microbiota in patients with idiopathic Parkinson's disease].
Li, Y., Li, R. X., Du, Y., Xu, X., Xue, Y., Gao, D., Gao, T., Sheng, Z., Zhang, L., & Tuo, H. (2020) · PubMed · doi:10.3760/cma.j.cn112137-20190702-01480 · Cited by 17 · see citing works
Karaki, S.-I., Tazoe, H., Kaji, I., Otomo, Y., Yajima, T., & Kuwahara, A. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)61717-5 · Cited by 10 · see citing works
Flagged first, then by citations
1 of the 71 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857 · see citing works
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 301 · see citing works
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 205 · see citing works
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M. J., Shukla, A. W., Ramirez‐Zamora, A., Mai, V., & Vedam‐Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 191 · see citing works
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177 · see citing works
Self-citationLiao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 175 · see citing works
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 155 · see citing works
Self-citationRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 146 · see citing works
Self-citationThe Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00730-8 · Cited by 134 · see citing works
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108 · see citing works
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101 · see citing works
Self-citationVaresi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Ma, Y., Li, X., Yu, J., & Wang, Y. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00404-1 · Cited by 87 · see citing works
Self-citationThe gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance
Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1890330 · Cited by 81 · see citing works
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Yu, L. W., Agirman, G., & Hsiao, E. Y. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-014237 · Cited by 75 · see citing works
Guo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82 · see citing works
Ağagündüz, D., Bingöl, F. G., Çelik, E., Cemali, Ö., Özenir, Ç., Özoğul, F., & Capasso, R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03609-y · Cited by 79 · see citing works
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 82 · see citing works
Leta, V., Chaudhuri, К. R., Milner, O., Chung‐Faye, G., Metta, V., Pariante, C. M., & Borsini, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.026 · Cited by 77 · see citing works
Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76 · see citing works
Liu, L., Wang, J., Wang, Y., Chen, L., Peng, L., Bin, Y., Ding, P., Zhang, R., Tong, F., & Dong, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03024-9 · Cited by 74 · see citing works
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69 · see citing works
Yan, Z., Yang, F., Sun, L., Yu, J., Sun, L., Si, Y., & Yao, L. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.09.009 · Cited by 71 · see citing works
Self-citationProbiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 75 · see citing works
Self-citationLiu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., Yang, W., Xie, H., Lü, Z., Chen, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.01.010 · Cited by 75 · see citing works
Self-citationLi, J., Liu, H., Wang, X., Xia, Y. F., Huang, J., Wang, T., Lin, Z., & Xiong, N. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00352-5 · Cited by 63 · see citing works
Liu, J., Ye, T., Zhang, Y., Zhang, R., Kong, Y., Zhang, Y., & Sun, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05038 · Cited by 61 · see citing works
Self-citationJiang, Z., Yin, X., Wang, M., Wang, Y., Li, F., Gao, Y., Han, G., Gao, Z., & Wang, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109451 · Cited by 61 · see citing works
Wu, H., Wei, J., Zhao, X., Liu, Y., Chen, Z., Wei, K., Lu, J., Chen, W., Jiang, M., Li, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10351 · Cited by 57 · see citing works
Hu, Y., & Tao, W. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.006 · Cited by 61 · see citing works
Probiotics and the Treatment of Parkinson's Disease: An Update
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01128-w · Cited by 57 · see citing works
Zhang, W., Chen, S., Huang, X., Tong, H., Niu, H., & Lu, L. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01549-0 · Cited by 60 · see citing works
Sun, Z., Gu, P., Xu, H., Zhao, W., Zhou, Y., Zhou, L., Zhang, Z., Wang, W., Han, R., Chai, X.-Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.808905 · Cited by 55 · see citing works
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products
Kim, D.-Y., Lee, S.-Y., Lee, J., Whon, T. W., Lee, J., Jeon, C. O., & Bae, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2412376 · Cited by 59 · see citing works
Sharma, N., Soni, R., Sharma, M., Chatterjee, S., Parihar, N., Mukarram, M., kale, R., Sayyed, A. A., Behera, S. K., & Khairnar, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03005-z · Cited by 54 · see citing works
Lee, Y. Z., Cheng, S.-H., Chang, M.-Y., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076794 · Cited by 54 · see citing works
Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023) · MedComm · doi:10.1002/mco2.268 · Cited by 50 · see citing works
Wang, Y., Chen, W., Han, Y., Xu, X., Yang, A., Wei, J., Hong, D., Fang, X., & Chen, T. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10505 · Cited by 52 · see citing works
Lv, X., Lü, Z., Tao, Y., Xie, H., Chen, Z., Lin, Y., Cai, X., Yang, W., Liao, X., Liu, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111116 · Cited by 50 · see citing works
Self-citationZhang, Y., Xu, S., Qian, Y., Mo, C., Ai, P., Yang, X., & Xiao, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1099018 · Cited by 49 · see citing works
Mao, Z., Hui, H., Zhao, X., Xu, L., Qi, Y., Yin, L., Qu, L., Han, L., & Peng, J. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.06.007 · Cited by 50 · see citing works
Huang, L., Lv, X., Ze, X., Ma, Z., Zhang, X., He, R., Fan, J., Zhang, M., Sun, B., Wang, F., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.990465 · Cited by 46 · see citing works
Skowron, K., Budzyńska, A., Wiktorczyk-Kapischke, N., Chomacka, K., Grudlewska‐Buda, K., Wilk, M., Wałecka-Zacharska, E., Andrzejewska, M., & Gospodarek-Komkowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147820 · Cited by 47 · see citing works
Zhou, M., Yuan, W., Yang, B., Pei, W., Ma, J., & Feng, Q. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-1670 · Cited by 43 · see citing works
Ling, Z., Jin, G., Yan, X., Cheng, Y., Shao, L., Song, Q., Liu, X., & Zhao, N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.886872 · Cited by 45 · see citing works
Self-citationExploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health
Cocean, A.-M., & Vodnar, D. C. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111073 · Cited by 48 · see citing works
Huang, L., Xiao, D., Sun, H., Qu, Y., & Su, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12699 · Cited by 40 · see citing works
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 46 · see citing works
Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Gubert, C., Gasparotto, J., & Morais, L. H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac017 · Cited by 40 · see citing works
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease
Saleh, M., Marković, M., Olson, K. E., Gendelman, H. E., & Mosley, R. L. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223278 · Cited by 40 · see citing works
Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 39 · see citing works
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 38 · see citing works
The gut microbiota modulate locomotion via vagus-dependent glucagon-like peptide-1 signaling
Lai, T.-T., Tsai, Y.-H., Liou, C.-W., Fan, C., Hou, Y.-T., Yao, T.-H., Chuang, H.-L., & Wu, W. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00477-w · Cited by 36 · see citing works
Aktaş, B., Aslım, B., & Özdemir, D. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-65061-w · Cited by 37 · see citing works
Li, Q., Meng, L., Chen, L., Shi, X., Tu, L., Zhou, Q. G., Yu, J.-L., Liao, X., Zeng, Y., & Yuan, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185375 · Cited by 36 · see citing works
Self-citationNeuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson’s Disease
Parra, I., Martínez, I., Vásquez-Celaya, L., Góngora-Alfaro, J. L., Tizabi, Y., & Mendieta, L. (2023) · Neurotoxicity Research · doi:10.1007/s12640-022-00627-y · Cited by 33 · see citing works
Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases
Bi, M., Liu, C., Wang, Y., & Liu, S. (2023) · Microorganisms · doi:10.3390/microorganisms11061527 · Cited by 34 · see citing works
Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease
Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Food & Function · doi:10.1039/d2fo03825k · Cited by 32 · see citing works
Gong, B., Li, C., Shi, Z., Wang, F., Dai, R., Chen, G., & Su, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675552 · Cited by 36 · see citing works
The Role of Immune Dysfunction in Parkinson’s Disease Development
Cossu, D., Hatano, T., & Hattori, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316766 · Cited by 29 · see citing works
Soni, D., Upadhayay, S., Dhureja, M., Arthur, R., & Kumar, P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01510-2 · Cited by 31 · see citing works
Gut microbiota and Parkinson’s disease
Wang, L., Cui, Y., Han, B., Du, Y., Salewala, K. S., Wang, S., Zhao, W., Zhang, H., Wang, S., Xu, X., et al. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003318 · Cited by 31 · see citing works
Sun, H.-Y., Wu, J. H., Wang, R., Zhang, S., Xu, H., Kaznacheyeva, E. V., Lu, X., Ren, H., & Wang, G. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01030-1 · Cited by 31 · see citing works
Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements
Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Saharan, B. S., Harshita, Duhan, J. S., & Gökşen, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300461 · Cited by 30 · see citing works
Microbiome-based therapeutics for Parkinson's disease
Hamilton, A. M., Krout, I. N., White, A. C., & Sampson, T. R. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00462 · Cited by 31 · see citing works
Effect of Different MPTP Administration Intervals on Mouse Models of Parkinson’s Disease
Ma, Y., & Rong, Q. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/2112146 · Cited by 29 · see citing works
Gao, W., Wang, Y., Wang, F., Wu, X., Lu, F., & Liu, F. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115590 · Cited by 28 · see citing works
Zheng, H., Zhang, C., Zhang, J., & Duan, L. (2023) · Protein & Cell · doi:10.1093/procel/pwad020 · Cited by 29 · see citing works
The promise of GLP-1 receptor agonists for neurodegenerative diseases
Athauda, D. S., Greig, N. H., Meissner, W. G., Foltynie, T., & Gandhi, S. (2026) · Journal of Clinical Investigation · doi:10.1172/jci194745 · Cited by 30 · see citing works
A multispecies probiotic accelerates fear extinction and inhibits relapse in mice: Role of microglia
Cui, X., Zhou, S., Xia, G., Chen, J., Jiang, L., Huang, J., & Tong, J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108613 · Cited by 26 · see citing works
Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
Sun, X., Li, X., Wang, Z., & Xie, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.878239 · Cited by 26 · see citing works
Liu, Y., Li, Z., Xu, Z., Zhang, B., Liu, A., He, Q., Zheng, F., & Zhan, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.011 · Cited by 25 · see citing works
The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment
Jia, X., Wang, Q., Liu, M., & Ding, J.-Y. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1415463 · Cited by 24 · see citing works
Evidence and possible mechanisms of probiotics in the management of type 1 diabetes mellitus
Dovi, K. S., Bajinka, O., & Conteh, I. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01006-2 · Cited by 26 · see citing works
Song, W., Zhou, Z.-M., Zhang, L., Shu, H.-F., Xia, J.-R., Qin, X., Hua, R., & Zhang, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07333-5 · Cited by 24 · see citing works
Yadav, S., & Raj, R. G. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.003 · Cited by 24 · see citing works
Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy
Guo, X., Song, D., Wu, M., Zhang, J., Li, J., & Yuan, L. (2025) · MedComm · doi:10.1002/mco2.70540 · Cited by 26 · see citing works
Aktaş, B. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01319-7 · Cited by 23 · see citing works
Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease
Zhang, W., Ye, Y., Song, J., Sang, T., Xia, T., Xie, L., Qiu, X., Zeng, Q., & Luo, X. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206157 · Cited by 27 · see citing works
Liu, Y., Li, J.-C., Gu, Y.-F., Qiu, R.-H., Huang, J., Xue, R., Li, S., Zhang, Y., Zhang, Y., & Zhang, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04102-2 · Cited by 24 · see citing works
Jia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22 · see citing works
Cheng, G., Liu, Z., Yan, Z., Wu, J., Li, Z., Gao, S., Zheng, C., Guo, S., Pan, Y., Chen, X., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.066 · Cited by 22 · see citing works
Naskar, A., Stezin, A., Dharmappa, A., Hegde, S., Philip, M., Kamble, N. L., Saini, J. S., Sandhya, K., Tatu, U. S., Yadav, R., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00019 · Cited by 22 · see citing works
Does gut brain axis has an impact on Parkinson’s disease (PD)?
Elangovan, A., Dahiya, B., Kirola, L., Iyer, M., Jeeth, P., Maharaj, S., Kumari, N., Lakhanpal, V., Michel, T. M., Rao, K. R. S. S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102171 · Cited by 22 · see citing works
Guo, L., Hu, H., Jiang, N., Yang, H., Sun, X., Xia, H., Ma, J., & Liu, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30819 · Cited by 23 · see citing works
Balakrishnan, R., Kang, S.-I., Lee, J. Y., Rho, Y., Kim, B.-K., & Choi, D. (2024) · Aging and Disease · doi:10.14336/ad.2024.1362 · Cited by 22 · see citing works
Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works
Kim, J. H., Choi, Y., Lee, S.-M., & Oh, M. S. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.215 · Cited by 21 · see citing works
Liu, J., Zhang, Y., Ye, T., Yu, Q., Yu, J., Yuan, S., Gao, X., Wan, X., Zhang, R., Han, W., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06998 · Cited by 20 · see citing works
Self-citationFeng, Y., & Hao, F. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104678 · Cited by 19 · see citing works
Peng, Z., Hou, T., Yang, K., Zhang, J., Mao, Y.-H., & Hou, X. (2025) · Nutrients · doi:10.3390/nu17111769 · Cited by 19 · see citing works
Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
Manfready, R. A., Engen, P. A., Metman, L. V., Sanzo, G., Goetz, C. G., Hall, D. A., Forsyth, C. B., Raeisi, S., Voigt, R. M., & Keshavarzian, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.660942 · Cited by 19 · see citing works
Shi, J., Wang, Y., Chen, D., Xu, X., Li, W., Li, K., He, J., Su, W., & Luo, Q. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12410-w · Cited by 19 · see citing works
An upconversion nanoplatform based multi-effective theatment for Parkinson’s disease
Hu, B., Fang, H., Huang, Z., Huang, W., Huang, W., Liu, H., Lv, F., Huang, W., & Wang, X. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142959 · Cited by 19 · see citing works
Panaitescu, P.-Ș., Răzniceanu, V., Mocrei-Rebrean, Ș.-M., Neculicioiu, V. S., Dragoș, H.-M., Costache, C. A., & Filip, G. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050244 · Cited by 18 · see citing works
Lin, H., Yin, L., Liu, W., Li, R., Jiang, T., Yang, M., Cao, Y., Wang, S., Yu, Y., Chen, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202410209 · Cited by 22 · see citing works
Oral Administration of Clostridium butyricum GKB7 Ameliorates Signs of Osteoarthritis in Rats
Chang, S. L., Lin, Y., Liu, S., Tsai, Y., Lin, S.-W., Chen, Y., Chen, C., Ko, C., Chen, H., Chen, W.-C., et al. (2022) · Cells · doi:10.3390/cells11142169 · Cited by 18 · see citing works
Microbial metabolites regulate social novelty via CaMKII neurons in the BNST
Liou, C.-W., Cheng, S., Yao, T.-H., Lai, T.-T., Tsai, Y.-H., Chien, C.-W., Kuo, Y., Chou, S.-H., Hsu, C., & Wu, W. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.029 · Cited by 19 · see citing works
Jia, L., Gong, Y., Jiang, X., Fan, X., Ji, Z., Ma, T., Li, R., & Liu, F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117887 · Cited by 18 · see citing works
- Authors
- Sun, J., Li, H., Jin, Y., Yu, J., Mao, S., Su, K.-P., Ling, Z., & Liu, J.
- Affiliations
- Wenzhou Medical University (CN)
- Taizhou Second People's Hospital (CN)
- China Medical University Hospital (TW)
- First Affiliated Hospital Zhejiang University (CN)
- Corresponding author
- Ling, Zongxin
- Liu, Jiaming
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 91
- Pages
- 703-715
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W3093878129
- Cited by
- 264
- References
- 71
- Citations by year
- 2026: 43 · 2025: 60 · 2024: 56 · 2023: 47 · 2022: 42 · 2021: 16
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971318)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Clostridium butyricum, Parkinson's disease, probiotics, gut microbiota, microbiota-gut-brain axis, motor impairment, MPTP-induced neurotoxicity, dopaminergic neuron loss, synaptic dysfunction, microglial activation, glucagon-like peptide-1, neuroprotection
- MeSH terms
- Gastrointestinal Microbiome, Animals, Disease Models, Animal, Male, Mice, Inbred C57BL, Parkinson Disease, RNA, Ribosomal, 16S, Neuroprotective Agents, Probiotics, Clostridium butyricum, Mice, Glucagon-Like Peptide 1, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
